India  

Covaxin

Latest news and video coverage curated from trusted media outlets

1
shares
ShareTweetSavePostSend
 
Which is the Best Covid Vaccine? II Covishield vs Covaxin vs Sputnik-V II FAQs Covid 19 Vaccine [Video]

Which is the Best Covid Vaccine? II Covishield vs Covaxin vs Sputnik-V II FAQs Covid 19 Vaccine

A million dollar question, which Covid vaccine is the best? Covishield, Covaxin, Sputnik-V or Moderna. You may often wonder what are the differences between different Covid 19 vaccines? and which..

Credit: Rumble     Duration: 10:44Published

You Might Like


What to watch on OTT this week

Explore a diverse range of content on OTT this week, from the hilarious banter of Koffee with Karan featuring Varun Dhawan and Sidharth Malhotra to the emotional rollercoaster of 'Aam Aadmi Family'..
IndiaTimes - Published

The Vaccine War script to be a featured in Oscar library

Vivek Agnihotri helmed 'The Vaccine War' has been invited by the Academy for their library. The Academy of Motion Picture Arts and Sciences reached out to the filmmaker, expressing interest in..
IndiaTimes - Published

Vivek announces BOGO for The Vaccine War

Vivek Agnihotri, director of 'The Vaccine War,' has announced a 'buy 1 get 1' ticket offer for the movie. The film has been doing well at the box office and Agnihotri wants to show appreciation to the..
IndiaTimes - Published

The Vaccine War struggles at the BO

Directed by Vivek Agnihotri, The Vaccine War is based on the book ‘Going Viral’ by Prof Balram Bhargava, Director General – Indian Council of Medical Research (ICMR). It talks about the..
IndiaTimes - Published

The Vaccine War BO day 1: the movie starts slow

'The Vaccine War' is touted to be India’s first ‘bio-science’ film as it tries to present the story of the scientists who developed India’s Covid-19 vaccine, Covaxin, during the pandemic.
IndiaTimes - Published

Covovax for adults to reach metros in a week: SII

Serum Institute of India’s CEO Adar Poonawalla told TOI on Friday that doses of Covovax — Covid booster shot for adults — would reach major cities in four to five days, while a Bharat Biotech..
IndiaTimes - Published

Covid jab Covovax as heterologous booster to be available on CoWIN soon; to cost Rs 225 per dose

Covovax can be administered to those who have already vaccinated with Covishield or Covaxin. The Drugs Controller General of India (DCGI) on January 16 had approved the market authorisation for Covovax..
IndiaTimes - Published

Amid rising viral cases, Bharat Biotech working on H3N2 vaccine

Amid rising cases of H3N2 influenza virus in the country and reports of some deaths too, Hyderabad-based vaccine maker Bharat Biotech, which developed the indigenous Covaxin and intranasal vaccine..
IndiaTimes - Published

Serum Institute seeks inclusion of Covid jab Covovax in CoWIN portal as heterologous booster dose for adults

Covid-19 vaccine India: The Drug Controller General of India (DCGI) on January 16 approved market authorisation for Covovax as a heterologous booster dose for adults who have been administered two..
Zee News - Published

Drug panel favours nod for Covovax as Covid booster

An expert panel of the central drug regulatory authority has recommended market authorisation for Serum Institute of India’s Covid vaccine, Covovax, as a heterologous booster dose for adults who have..
IndiaTimes - Published

Covovax may get approval as heterologous booster

The government may decide on allowing Serum Institute of India’s (SII) Covovax as a heterologous booster dose, meaning it can be used for people who have taken either Covishield or Covaxin for..
IndiaTimes - Published

Ocugen announces positive top-line data for Covaxin in US trials


newKerala.com - Published

Delhi HC makes Bharat Biotech, Centre parties in pleas seeking details on Covaxin


newKerala.com - Published

Ocugen-Bharat Biotech Covid vaccine Covaxin meets main goals in US trial

Ocugen Inc said on Monday the Covid-19 vaccine developed by its Indian partner Bharat Biotech International Ltd met the main goals of a trial in the United States. The vaccine, sold under brand name..
IndiaTimes - Published

Covid-19: Vaccination figures jump three-fold in Mumbai

Govt-run centres only have Covaxin; state writes to Centre seeking Covishield, Corbevax
Mid-Day - Published

Bharat Biotech's nasal vaccine to be priced at Rs 800/dose in pvt markets, Rs 325/dose for governments

Bharat Biotech on Tuesday said that its intranasal Covid-19 vaccine iNCOVACC will be priced at Rs 800 per dose for the private markets and Rs 325 per dose for central and state governments. The company..
IndiaTimes - Published

Noida residents experience vaccination shortage: Check where Covid-19 vaccine, booster dose are available

Noida residents experienced shortage of Covaxin and Covishield on Saturday, check out where you can get Covid-19 vaccine and booster dose.
DNA - Published

Explained: Covid-19 nasal vaccine available now, know how it works and who can take

The nasal vaccine can be administered as a heterologous booster dose by people who have already received Covishield and Covaxin.
DNA - Published

Mumbai: No takers, no stock for Covid-19 vaccines

With interest waning, BMC has also run out of Covishield and Corbevax stock, with just a few thousand doses of Covaxin left
Mid-Day - Published

Government rejects claims of rushed approval for Covaxin due to 'political pressure'


newKerala.com - Published

Health Ministry rejects claim 'Covaxin was rushed due to political pressure'


newKerala.com - Published

No external pressure to accelerate Covaxin development: Bharat Biotech


newKerala.com - Published

`Misleading, fallacious`: Govt rubbishes media reports claiming Covaxin approval due to political pressure

The Central Drugs Standard Control Organization's Subject Expert Committee met on January 1 and 2, 2021 and made recommendations on Bharat Biotech's proposal for Restricted Emergency Approval of the..
Zee News - Published

Indian govt, Bharat Biotech rubbish reports of Covaxin development being rushed under political pressure


IndiaTimes - Published

Govt: Sputnik V recipients can take Covishield, Covaxin booster


IndiaTimes - Published

India widens Covid-19 vaccine basket, Corbevax to be available as booster dose for all adults from THIS date

Those adults who got vaccinated with either Covaxin or Covishield will now be allowed to take the Corbevax dose, six months or 26 weeks after administration of the second dose.
Zee News - Published

Corbevax approved as precaution dose for adults vaccinated with Covaxin, Covishield


newKerala.com - Published Also reported by •Indian ExpressDNAZee NewsIndiaTimes

Corbevax gets nod as booster after Covishield, Covaxin shots


IndiaTimes - Published

India to start Covid mix-and-match booster vaccines on Friday

India said on Wednesday that Biological E's Covid-19 vaccine Corbevax can be administered as a booster dose in people who have taken the country's other two main shots, Covaxin and AstraZeneca's..
IndiaTimes - Published

Mix and match: Centre okays Corbevax as booster for those who got Covishield or Covaxin


Indian Express - Published Also reported by •IndiaTimes

Biological E's Corbevax gets go ahead for use as booster for Covaxin, Covishield

In what is the first heterologous booster shot to be approved, Biological E’s Covid-19 vaccine Corbevax is learnt to have received the government’s nod for use as a booster or precaution dose for..
IndiaTimes - Published

Government nod for Corbevax as booster for adults vaccinated with Covishield, Covaxin soon


Indian Express - Published Also reported by •IndiaTimes

Japan approves COVAXIN booster dose for travellers: Bharat Biotech


newKerala.com - Published

Japan allows Covaxin boosted travellers to visit country


IndiaTimes - Published

Covid-19: Covaxin booster has 77.8 per cent efficacy against variants

Health experts say the study has put the indigenous vaccine among global ones, but add that it needs long-term studies
Mid-Day - Published

Covaxin booster dose increases immune response by 40 times, gives long-term immunity against COVID-19: Bharat Biotech


newKerala.com - Published Also reported by •IndiaTimes

Covaxin can help control virus load, reduce disease severity: Study


newKerala.com - Published

Covaxin booster dose safe, ensures persistent immunity to minimise breakthrough Covid infections: Study


Indian Express - Published

NTAGI approves Corbevax, Covaxin for 5-12 yrs age group: Sources


newKerala.com - Published Also reported by •IndiaTimes

Biological E's Corbevax, Bharat Biotech's Covaxin get NTAGI's nod for use children aged 5-12 years

Prime Minister Narendra Modi emphasised that all eligible children get the Covid-19 vaccine as soon as possible via "special programmes" in schools.
DNA - Published

NTAGI panel recommends use of Covid vaccines Corbevax, Covaxin for kids aged 5-12 years


Indian Express - Published

Corbevax being considered as booster dose for Covishield, Covaxin jabbed people

NTAGI is considering using Corbevax as a booster vaccination against Covid-19.
DNA - Published


 Page 1  〉